info@businessghana.com
A single video posted by Michelle Sekwena has turned a deeply personal medical journey into a national health conversation, one that many women didn’t realise they needed to have.
Nearly a year after undergoing a breast reduction in early 2024, reportedly moving from a 34G to a 34D, Sekwena shared a TikTok update that quickly went viral. Viewers noticed something striking: her breast size appeared to have returned close to her pre-surgery size.
Within hours, social media timelines lit up. On platforms like TikTok and X, women across South Africa began asking the same urgent question:
“Can breasts grow back after a reduction?”
I’m a victim of that ???? https://t.co/GOTzYIOdAz pic.twitter.com/or0c2qFwSD
— Kedibone (@Ronaele__) April 13, 2026
For many, Sekwena’s experience has shifted from viral curiosity to something far more serious: a spotlight on gigantomastia, a rare medical condition that remains widely misunderstood.
Breast reduction surgery, medically known as reduction mammaplasty, is often seen as life-changing. It promises relief from chronic back pain, limited mobility, posture strain, and emotional distress tied to extremely large breasts.
But Sekwena’s visible regrowth has shaken that perception, prompting deeper conversations about breast reduction outcomes, breast tissue regrowth, and the biological realities behind rare conditions like gigantomastia.
To unpack the science, Independent Media Lifestyle consulted Dr Judey Pretorius, who explained that gigantomastia is far more complex than most people assume.
“Gigantomastia is a rare condition characterised by excessive and rapid growth of breast tissue, often to a degree that it becomes physically debilitating,” Pretorius shared. Crucially, it’s not always caused by abnormal hormone levels.
“In many patients, circulating hormone levels, particularly oestrogen and progesterone, may fall within normal ranges, yet the breast tissue responds in an exaggerated manner.”
That exaggerated response points to something scientists call receptor hypersensitivity, when breast tissue becomes unusually reactive to normal hormonal signals.
One of the most confronting truths for patients is this: surgery treats the symptom, not always the cause.
“When regrowth occurs, it is a clear indication that the underlying biological drivers of the condition remain active,” Pretorius said.
“Surgery removes excess tissue, but it does not alter the hormonal environment or the tissue’s intrinsic sensitivity to those hormones.” In simple terms, if the body is biologically wired to grow breast tissue aggressively, any remaining tissue after surgery can continue growing, sometimes rapidly.
For women watching Sekwena’s journey unfold online, this reality has been both shocking and validating. Because for many, breast reduction isn’t cosmetic, it’s survival, comfort and dignity.
Gigantomastia doesn’t appear randomly. It often emerges during life stages marked by major hormonal changes. “Puberty and pregnancy are the most commonly reported triggers,” explained Pretorius.
These periods flood the body with hormones like oestrogen, progesterone, and prolactin, all of which stimulate breast development. For individuals with underlying sensitivity, that normal process can spiral into excessive growth.
Pregnancy-related gigantomastia, in particular, can escalate quickly due to sustained hormonal stimulation. Menopause is less commonly linked, but hormone replacement therapy may also act as a trigger in some cases.
What makes this especially challenging is that there are currently no reliable biomarkers to predict recurrence.
That uncertainty leaves many patients navigating fear alone. While the physical symptoms are visible, the emotional impact often stays hidden. Living with recurrent gigantomastia can feel like a cycle of anticipation and disappointment, relief after surgery, followed by anxiety if regrowth begins.
“The psychological impact can be profound,” Pretorius explained.
Patients often deal with chronic pain, limited movement, and drastic body image changes, all while feeling a loss of control over their own bodies. “When the condition recurs, it can create a sense of loss of control over one’s own body.”
That loss isn’t just physical; it’s deeply personal. Confidence shifts. Identity shifts. Even daily routines shift. For many women watching Sekwena’s story unfold, that emotional reality feels painfully familiar.
Medical experts are increasingly calling for a multidisciplinary approach to conditions like gigantomastia. That means combining surgery with hormonal monitoring, psychological support, and in some cases medication aimed at reducing breast tissue stimulation.
“In cases where surgery is not sufficient, adjunctive strategies may include hormonal therapies aimed at reducing stimulation of breast tissue,” added Pretorius.
Researchers are also exploring targeted therapies that focus on cellular signalling pathways, a promising area of biomedical research that could one day transform treatment outcomes.
But for now, treatment remains highly individualised.
